Clarivate Reports Fourth Quarter and Full Year 2024 Results

— Accelerates transition from transactional to subscription and re-occurring revenue —— Launches new product innovation for Academia & Government and Life Sciences & Healthcare — — Repurchased $200 million ordinary shares and pre-paid$198 million of debt in 2024 as part of balanced capital allocation strategy —— Initiates review of strategic alternatives including potential divestitures —— Provides 2025 Outlook —LONDON, Feb. 19, 2025 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT) (the "Company" or "Clarivate") ...